CARA THERAPEUTICS INC's ticker is CARA and the CUSIP is 140755109. A total of 157 filers reported holding CARA THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.47 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $26,742 | -44.8% | 15,918 | -7.0% | 0.00% | – |
| Q2 2023 | $48,416 | -40.2% | 17,108 | +3.7% | 0.00% | – |
| Q1 2023 | $81,010 | -53.0% | 16,499 | +2.7% | 0.00% | -100.0% |
| Q4 2022 | $172,463 | +1816.3% | 16,058 | +1447.0% | 0.00% | – |
| Q2 2022 | $9,000 | -71.9% | 1,038 | -60.4% | 0.00% | – |
| Q1 2022 | $32,000 | +77.8% | 2,623 | +77.0% | 0.00% | – |
| Q4 2021 | $18,000 | -33.3% | 1,482 | -14.4% | 0.00% | – |
| Q3 2021 | $27,000 | -58.5% | 1,732 | -42.3% | 0.00% | -100.0% |
| Q1 2021 | $65,000 | +44.4% | 3,000 | 0.0% | 0.00% | 0.0% |
| Q4 2020 | $45,000 | +40.6% | 3,000 | +20.0% | 0.00% | 0.0% |
| Q3 2020 | $32,000 | -27.3% | 2,500 | 0.0% | 0.00% | 0.0% |
| Q2 2020 | $44,000 | -46.3% | 2,500 | -44.4% | 0.00% | -66.7% |
| Q3 2019 | $82,000 | -15.5% | 4,500 | 0.0% | 0.00% | -25.0% |
| Q2 2019 | $97,000 | +1.0% | 4,500 | -8.2% | 0.00% | 0.0% |
| Q1 2019 | $96,000 | +50.0% | 4,900 | 0.0% | 0.00% | +33.3% |
| Q4 2018 | $64,000 | -23.8% | 4,900 | +40.0% | 0.00% | -25.0% |
| Q3 2018 | $84,000 | +75.0% | 3,500 | +40.0% | 0.00% | +33.3% |
| Q2 2018 | $48,000 | +4700.0% | 2,500 | +2400.0% | 0.00% | – |
| Q1 2018 | $1,000 | – | 100 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RHO CAPITAL PARTNERS INC | 2,799,058 | $42,350,000 | 22.29% |
| Chescapmanager LLC | 1,314,603 | $19,890,000 | 2.42% |
| Prosight Management, LP | 294,041 | $4,449,000 | 2.06% |
| DAFNA Capital Management LLC | 261,442 | $3,956,000 | 1.18% |
| Cypress Capital Management LLC (WY) | 81,269 | $1,230,000 | 1.06% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 626,583 | $9,480,000 | 1.02% |
| Carmignac Gestion | 1,851,443 | $28,012,000 | 0.29% |
| FARALLON CAPITAL MANAGEMENT LLC | 2,465,000 | $37,295,000 | 0.22% |
| Ikarian Capital, LLC | 301,700 | $4,565,000 | 0.20% |
| DISCIPLINED GROWTH INVESTORS INC /MN | 689,899 | $10,438,000 | 0.20% |